Keywords
Last Name
Institution

SANKAR DASS NAVANEETHAN

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Nephrology
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Snitker S, Doerfler RM, Soliman EZ, Deo R, St Peter WL, Kramlik S, Fischer MJ, Navaneethan S, Delafontaine P, Jaar BG, Ojo A, Makos GK, Slaven A, Weir MR, Zhan M, Fink JC. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. Clin J Am Soc Nephrol. 2017 Aug 09. PMID: 28793999.
      View in: PubMed
    2. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Aug 04. PMID: 28778854.
      View in: PubMed
    3. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 Jul 24. PMID: 28750929.
      View in: PubMed
    4. Navaneethan SD, Virani SS. Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk. J Am Heart Assoc. 2017 Jul 14; 6(7). PMID: 28710179.
      View in: PubMed
    5. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 02 16; 376(7):641-651. PMID: 28199805.
      View in: PubMed
    6. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV. Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD. Am J Kidney Dis. 2017 Feb 10. PMID: 28196649.
      View in: PubMed
    7. Chang AR, Grams ME, Navaneethan SD. Bariatric Surgery and Kidney-Related Outcomes. Kidney Int Rep. 2017 Mar; 2(2):261-270. PMID: 28439568.
      View in: PubMed
    8. Chirakarnjanakorn S, Navaneethan SD, Francis GS, Tang WH. Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. Int J Cardiol. 2017 Jan 04. PMID: 28108129.
      View in: PubMed
    9. Walther CP, Navaneethan SD. Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease. J Am Soc Nephrol. 2017 Jan 03. PMID: 28049650.
      View in: PubMed
    10. Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. Kidney Int. 2016 Dec 22. PMID: 28017325.
      View in: PubMed
    11. Airy M, Winkelmayer WC, Navaneethan SD. Phosphate Binders: The Evidence Gap Persists. Am J Kidney Dis. 2016 Nov; 68(5):667-670. PMID: 27772629.
      View in: PubMed
    12. Kirwan JP, Malin SK, Scelsi AR, Kullman EL, Navaneethan SD, Pagadala MR, Haus JM, Filion J, Godin JP, Kochhar S, Ross AB. A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. J Nutr. 2016 Nov; 146(11):2244-2251. PMID: 27798329.
      View in: PubMed
    13. Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, Wolf M. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol. 2016 Aug 1; 1(5):548-56. PMID: 27434583; PMCID: PMC4992989 [Available on 08/01/17].
    14. Agrawal V, Navaneethan SD. Bariatric surgery for obesity-associated decline in kidney function: filling the knowledge gap? Kidney Int. 2016 Jul; 90(1):28-30. PMID: 27312446.
      View in: PubMed
    15. Yan J, Navaneethan SD. Copeptin and Decline in Kidney Function. Am J Nephrol. 2016; 44(1):19-21. PMID: 27348731.
      View in: PubMed
    16. Nigwekar SU, Kang A, Zoungas S, Cass A, Gallagher MP, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli GF, Jardine MJ. Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database Syst Rev. 2016; (5):CD004683. PMID: 27243372.
      View in: PubMed
    17. Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2016 May 24. PMID: 27220754.
      View in: PubMed
    18. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 Sep; 68(3):414-21. PMID: 27130720; PMCID: PMC5002238 [Available on 09/01/17].
    19. Williams MF, London DA, Husni EM, Navaneethan S, Kashyap SR. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complications. 2016 Jul; 30(5):944-50. PMID: 27114387.
      View in: PubMed
    20. Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46. PMID: 26891053; PMCID: PMC4794258 [Available on 02/19/17].
    21. Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82. PMID: 26880461; PMCID: PMC4757850 [Available on 03/01/17].
    22. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016 Jan 12; 315(2):164-74. PMID: 26757465.
      View in: PubMed
    23. Navaneethan SD, Fealy CE, Scelsi AC, Arrigain S, Malin SK, Kirwan JP. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease. Am J Nephrol. 2015; 42(4):274-81. PMID: 26495987.
      View in: PubMed
    24. Andalib A, Aminian A, Khorgami Z, Navaneethan SD, Schauer PR, Brethauer SA. Safety analysis of primary bariatric surgery in patients on chronic dialysis. Surg Endosc. 2016 Jun; 30(6):2583-91. PMID: 26416373.
      View in: PubMed
    25. Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, Flack JM, Ojo AO, Plappert TJ, Raj DS, Saydain G, Sondheimer JH, Sood R, Steigerwalt SP, Townsend RR, Dweik RA, Rahman M. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. J Am Soc Nephrol. 2016 Mar; 27(3):877-86. PMID: 26386072; PMCID: PMC4769189 [Available on 03/01/17].
    26. Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS. GFR Estimation Using ?-Trace Protein and ?2-Microglobulin in CKD. Am J Kidney Dis. 2016 Jan; 67(1):40-8. PMID: 26362696.
      View in: PubMed
    27. Sharma S, Navaneethan SD. Predicting Mortality after Severe Acute Kidney Injury: A Step Forward but Not Close to the Finish Line. Am J Nephrol. 2015; 42(1):54-6. PMID: 26303823.
      View in: PubMed
    28. Navaneethan SD, Whaley-Connell A. BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues. Clin J Am Soc Nephrol. 2015 Sep 4; 10(9):1501-3. PMID: 26276139.
      View in: PubMed
    29. Denker M, Boyle S, Anderson AH, Appel LJ, Chen J, Fink JC, Flack J, Go AS, Horwitz E, Hsu CY, Kusek JW, Lash JP, Navaneethan S, Ojo AO, Rahman M, Steigerwalt SP, Townsend RR, Feldman HI. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol. 2015 Nov 6; 10(11):2073-83. PMID: 26265715.
      View in: PubMed
    30. Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV, Navaneethan SD. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease. Am J Nephrol. 2015; 41(6):456-63. PMID: 26228532.
      View in: PubMed
    31. Saeed F, Adil MM, Vidal GA, Piracha BH, Nahab F, Salam Khan A, Navaneethan SD. Outcomes of transient ischemic attack in maintenance dialysis patients and those with chronic kidney disease. Nephrol Dial Transplant. 2016 Jan; 31(1):128-32. PMID: 26160895.
      View in: PubMed
    32. Navaneethan SD, Dweik RA. Elevated pulmonary pressure: A novel risk marker in kidney disease? Kidney Int. 2015 Jul; 88(1):7-9. PMID: 26126087.
      View in: PubMed
    33. Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 7; 10(7):1119-27. PMID: 26111859.
      View in: PubMed
    34. Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8. PMID: 26077569.
      View in: PubMed
    35. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV. Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol. 2015 Oct; 26(10):2512-20. PMID: 26045089.
      View in: PubMed
    36. Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine MJ. Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Cochrane Database Syst Rev. 2015; 5:CD007910. PMID: 25938479.
      View in: PubMed
    37. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015; 16:69. PMID: 26024966.
      View in: PubMed
    38. Navaneethan SD, Boulware LE, Sedor JR. Patients as stakeholders in setting kidney disease research priorities. Am J Kidney Dis. 2015 May; 65(5):641-3. PMID: 25919496.
      View in: PubMed
    39. Liu F, Bennett S, Arrigain S, Schold J, Heyka R, McLennan G, Navaneethan SD. Patency and Complications of Translumbar Dialysis Catheters. Semin Dial. 2015 Jul-Aug; 28(4):E41-7. PMID: 25800550.
      View in: PubMed
    40. Navaneethan SD, Malin SK, Arrigain S, Kashyap SR, Kirwan JP, Schauer PR. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis. 2015 Feb; 65(2):345-7. PMID: 25458664.
      View in: PubMed
    41. Wilson FP, Xie D, Anderson AH, Leonard MB, Reese PP, Delafontaine P, Horwitz E, Kallem R, Navaneethan S, Ojo A, Porter AC, Sondheimer JH, Sweeney HL, Townsend RR, Feldman HI. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol. 2014 Dec 5; 9(12):2095-103. PMID: 25381342.
      View in: PubMed
    42. Opelami O, Sakhuja A, Liu X, Tang WH, Schold JD, Navaneethan SD. Outcomes of infected cardiovascular implantable devices in dialysis patients. Am J Nephrol. 2014; 40(3):280-7. PMID: 25323128.
      View in: PubMed
    43. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014 Oct; 37(10):2864-83. PMID: 25249672.
      View in: PubMed
    44. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014 Oct; 64(4):510-33. PMID: 25257325.
      View in: PubMed
    45. Saab G, Lam M, Navaneethan SD, Slatopolsky E. Should monitoring of fibroblast growth factor-23 levels in dialysis patients be a part of routine clinical practice? Semin Dial. 2014 Nov-Dec; 27(6):565-8. PMID: 25040017.
      View in: PubMed
    46. Saab G, Navaneethan SD, Slatopolsky E. Targeting parathyroid hormone levels in dialysis patients. Semin Dial. 2014 Nov-Dec; 27(6):562-5. PMID: 25040125.
      View in: PubMed
    47. Navaneethan SD, Kirwan JP, Arrigain S, Schold JD. Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004. BMC Nephrol. 2014; 15:108. PMID: 25005601.
      View in: PubMed
    48. Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25. PMID: 24887302.
      View in: PubMed
    49. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2014; 5:CD007784. PMID: 24880031.
      View in: PubMed
    50. Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2014; 4:CD007004. PMID: 24782282.
      View in: PubMed
    51. Hawkins M, Newman AB, Madero M, Patel KV, Shlipak MG, Cooper J, Johansen KL, Navaneethan SD, Shorr RI, Simonsick EM, Fried LF. TV Watching, but Not Physical Activity, Is Associated With Change in Kidney Function in Older Adults. J Phys Act Health. 2015 Apr; 12(4):561-8. PMID: 24762526.
      View in: PubMed
    52. Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014 Sep; 64(3):367-74. PMID: 24726629.
      View in: PubMed
    53. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV. Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality. Am J Nephrol. 2014; 39(4):288-96. PMID: 24714513.
      View in: PubMed
    54. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014 May 22; 370(21):2002-13. PMID: 24679060.
      View in: PubMed
    55. Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GF. Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2014; 3:CD009297. PMID: 24683046.
      View in: PubMed
    56. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May; 9(5):855-63. PMID: 24578332.
      View in: PubMed
    57. Wing MR, Yang W, Teal V, Navaneethan S, Tao K, Ojo A, Guzman NN, Reilly M, Wolman M, Rosas SE, Cuevas M, Fischer M, Lustigova E, Master SR, Xie D, Appleby D, Joffe M, Kusek J, Feldman HI, Raj DS. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study. Obesity (Silver Spring). 2014 May; 22(5):1359-66. PMID: 24415732.
      View in: PubMed
    58. Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15. PMID: 24508475.
      View in: PubMed
    59. Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2014; 1:CD005019. PMID: 24470059.
      View in: PubMed
    60. Kelly KR, Navaneethan SD, Solomon TP, Haus JM, Cook M, Barkoukis H, Kirwan JP. Lifestyle-induced decrease in fat mass improves adiponectin secretion in obese adults. Med Sci Sports Exerc. 2014; 46(5):920-6. PMID: 24614337.
      View in: PubMed
    61. Stephen R, Jolly SE, Nally JV, Navaneethan SD. Albuminuria: when urine predicts kidney and cardiovascular disease. Cleve Clin J Med. 2014 Jan; 81(1):41-50. PMID: 24391106.
      View in: PubMed
    62. Malin SK, Navaneethan SD, Mulya A, Huang H, Kirwan JP. Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults. J Nutr Health Aging. 2014; 18(6):608-15. PMID: 24950152.
      View in: PubMed
    63. Sakhuja A, Schold JD, Kumar G, Katzan I, Navaneethan SD. Nontraumatic subarachnoid hemorrhage in maintenance dialysis hospitalizations: trends and outcomes. Stroke. 2014 Jan; 45(1):71-6. PMID: 24253541.
      View in: PubMed
    64. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2013; 9:CD004289. PMID: 24022428.
      View in: PubMed
    65. Navaneethan SD, Bravo EL. Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers? Clin J Am Soc Nephrol. 2013 Oct; 8(10):1637-9. PMID: 23929926.
      View in: PubMed
    66. Ohashi Y, Thomas G, Nurko S, Stephany B, Fatica R, Chiesa A, Rule AD, Srinivas T, Schold JD, Navaneethan SD, Poggio ED. Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant. 2013 Sep; 13(9):2342-51. PMID: 23865821.
      View in: PubMed
    67. Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10. PMID: 23769134.
      View in: PubMed
    68. Sakhuja A, Schold JD, Kumar G, Dall A, Sood P, Navaneethan SD. Outcomes of patients receiving maintenance dialysis admitted over weekends. Am J Kidney Dis. 2013 Oct; 62(4):763-70. PMID: 23669002.
      View in: PubMed
    69. Garg N, Thomas G, Jackson G, Rickard J, Nally JV, Tang WH, Navaneethan SD. Cardiac resynchronization therapy in CKD: a systematic review. Clin J Am Soc Nephrol. 2013 Aug; 8(8):1293-303. PMID: 23660183.
      View in: PubMed
    70. Navaneethan SD, Jolly SE, Sharp J, Jain A, Schold JD, Schreiber MJ, Nally JV. Electronic health records: a new tool to combat chronic kidney disease? Clin Nephrol. 2013 Mar; 79(3):175-83. PMID: 23320972.
      View in: PubMed
    71. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52. PMID: 23411425.
      View in: PubMed
    72. Nigwekar SU, Strippoli GF, Navaneethan SD. Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev. 2013; 1:CD006740. PMID: 23440810.
      View in: PubMed
    73. Babayev R, Whaley-Connell A, Kshirsagar A, Klemmer P, Navaneethan S, Chen SC, Li S, McCullough PA, Bakris G, Bomback A. Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 Mar; 61(3):404-12. PMID: 23260275.
      View in: PubMed
    74. Boulware LE, Tangri N, Ephraim PL, Scialla JJ, Sozio SM, Crews DC, Shafi T, Miskulin DC, Liu J, St Peter W, Jaar BG, Wu AW, Powe NR, Navaneethan SD, Bandeen-Roche K. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012; 13:167. PMID: 23217181.
      View in: PubMed
    75. Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA, Schauer PR. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013 Jan-Feb; 9(1):7-14. PMID: 23211651.
      View in: PubMed
    76. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sarnak MJ, Schold JD. Obesity, anthropometric measures and chronic kidney disease complications. Am J Nephrol. 2012; 36(3):219-27. PMID: 22948230.
      View in: PubMed
    77. Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012 Aug 21; 157(4):263-75. PMID: 22910937.
      View in: PubMed
    78. Sullivan C, Leon JB, Sayre SS, Marbury M, Ivers M, Pencak JA, Bodziak KA, Hricik DE, Morrison EJ, Albert JM, Navaneethan SD, Reyes CM, Sehgal AR. Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol. 2012 Oct; 7(10):1639-45. PMID: 22798540.
      View in: PubMed
    79. Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ. 2012; 344:e3533. PMID: 22695899.
      View in: PubMed
    80. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M. Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1155-62. PMID: 22554719.
      View in: PubMed
    81. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ, Sarnak MJ, Nally JV. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant. 2012 Aug; 27(8):3228-34. PMID: 22553369.
      View in: PubMed
    82. Strippoli GF. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol. 2012 Jun; 7(6):974-81. PMID: 22490876.
      View in: PubMed
    83. Fissell RB, Srinivas T, Fatica R, Nally J, Navaneethan S, Poggio E, Goldfarb D, Schold J. Preemptive renal transplant candidate survival, access to care, and renal function at listing. Nephrol Dial Transplant. 2012 Aug; 27(8):3321-9. PMID: 22422867.
      View in: PubMed
    84. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sehgal AR, Schold JD. Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond). 2012 Dec; 36(12):1585-90. PMID: 22290538.
      View in: PubMed
    85. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study. Nephrol Dial Transplant. 2012 Jun; 27(6):2479-88. PMID: 22207325.
      View in: PubMed
    86. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402. PMID: 21885787.
      View in: PubMed
    87. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2364-73. PMID: 21852664.
      View in: PubMed
    88. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ, Simon JF, Srinivas TR, Nally JV. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43. PMID: 21816525.
      View in: PubMed
    89. Raina R, Simon JF, Marion CR, Valeria A, Navaneethan SD, Heresi GA, Guzman JA, Wehbe E, Nally JV. Unusual cases of hydronephrosis with retroperitoneal fibrosis: mystery revealed. NDT Plus. 2011 Oct; 4(5):313-317. PMID: 21969844.
      View in: PubMed
    90. Demirjian SG, Raina R, Bhimraj A, Navaneethan SD, Gordon SM, Schreiber MJ, Guzman JA. 2009 influenza A infection and acute kidney injury: incidence, risk factors, and complications. Am J Nephrol. 2011; 34(1):1-8. PMID: 21625080.
      View in: PubMed
    91. Wehbe E, Salem C, Simon JF, Navaneethan SD, Pohl M. IgA-dominant Staphylococcus infection-associated glomerulonephritis: case reports and review of the literature. NDT Plus. 2011 Jun; 4(3):181-5. PMID: 25984152.
      View in: PubMed
    92. Maione A, Navaneethan SD, Graziano G, Mitchell R, Johnson D, Mann JF, Gao P, Craig JC, Tognoni G, Perkovic V, Nicolucci A, De Cosmo S, Sasso A, Lamacchia O, Cignarelli M, Manfreda VM, Gentile G, Strippoli GF. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials. Nephrol Dial Transplant. 2011 Sep; 26(9):2827-47. PMID: 21372254.
      View in: PubMed
    93. Navaneethan SD, Hegbrant J, Strippoli GF. Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2011 Mar; 20(2):146-52. PMID: 21245764.
      View in: PubMed
    94. Navaneethan SD, Palmer SC, Vecchio M, Craig JC, Elder GJ, Strippoli GF. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database Syst Rev. 2011; (2):CD006023. PMID: 21328279.
      View in: PubMed
    95. Srinivas TR, Flechner SM, Poggio ED, Askar M, Goldfarb DA, Navaneethan SD, Schold JD. Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation. 2010 Dec 27; 90(12):1499-505. PMID: 21085061.
      View in: PubMed
    96. Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, Ruospo M, Querques M, Jannini EA, Strippoli GF. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev. 2010; (12):CD007747. PMID: 21154382.
      View in: PubMed
    97. Smith A, Palmer S, Johnson DW, Navaneethan S, Valentini M, Strippoli GF. How to conduct a randomized trial. Nephrology (Carlton). 2010 Dec; 15(8):740-6. PMID: 21175959.
      View in: PubMed
    98. Navaneethan SD, Palmer SC, Smith A, Johnson DW, Strippoli GF. How to design a randomized controlled trial. Nephrology (Carlton). 2010 Dec; 15(8):732-9. PMID: 21091924.
      View in: PubMed
    99. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504. PMID: 21115622.
      View in: PubMed
    100. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ, Jain A, Nally JV. Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol. 2011 Jan; 6(1):40-9. PMID: 21051745.
      View in: PubMed
    101. Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, Lucisano G, Craig JC, Ruospo M, Gentile G, Manfreda VM, Querques M, Stroumza P, Torok M, Celia E, Gelfman R, Ferrari JN, Bednarek-Skublewska A, Dulawa J, Bonifati C, Hegbrant J, Wollheim C, Jannini EA, Strippoli GF. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis. 2010 Oct; 56(4):670-85. PMID: 20801572.
      View in: PubMed
    102. Kandula P, Dobre M, Schold JD, Schreiber MJ, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011 Jan; 6(1):50-62. PMID: 20876671.
      View in: PubMed
    103. Schold JD, Sehgal AR, Srinivas TR, Poggio ED, Navaneethan SD, Kaplan B. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant. 2010 Sep; 10(9):2008-16. PMID: 20645941.
      View in: PubMed
    104. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med. 2010 Jul 6; 153(1):23-33. PMID: 20439566.
      View in: PubMed
    105. Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Querques M, Saglimbene V, Ruospo M, Bonifati C, Jannini EA, Strippoli GF. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol. 2010 Jun; 5(6):985-95. PMID: 20498250.
      View in: PubMed
    106. Jeevanantham V, Ntim W, Navaneethan SD, Shah S, Johnson AC, Hall B, Shah A, Hundley WG, Daubert JP, Fitzgerald D. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am J Cardiol. 2010 May 1; 105(9):1317-26. PMID: 20403486.
      View in: PubMed
    107. Navaneethan SD, Kandula P, Jeevanantham V, Nally JV, Liebman SE. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. Clin Nephrol. 2010 Apr; 73(4):260-7. PMID: 20353733.
      View in: PubMed
    108. Dobre M, Demirjian S, Sehgal AR, Navaneethan SD. Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol. 2011 Mar; 43(1):175-84. PMID: 20306131.
      View in: PubMed
    109. Kandula P, Shah R, Singh N, Markwell SJ, Bhensdadia N, Navaneethan SD. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention. Nephrology (Carlton). 2010 Mar; 15(2):165-70. PMID: 20470274.
      View in: PubMed
    110. Palmer SC, Navaneethan SD, Strippoli GF. How to read a nephrology systematic review. Nephrology (Carlton). 2010 Mar; 15(2):158-64. PMID: 20470273.
      View in: PubMed
    111. Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg. 2010 Mar; 20(3):308-15. PMID: 20217955.
      View in: PubMed
    112. Navaneethan SD, Schold JD, Srinivas TR. Metabolic syndrome and mild to moderate chronic kidney disease among minorities. Semin Nephrol. 2010 Jan; 30(1):51-8. PMID: 20116648.
      View in: PubMed
    113. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev. 2009; (4):CD006028. PMID: 19821351.
      View in: PubMed
    114. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Oct; 4(10):1565-74. PMID: 19808241.
      View in: PubMed
    115. Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009 Oct; 54(4):619-37. PMID: 19692157.
      View in: PubMed
    116. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2009; (3):CD007004. PMID: 19588415.
      View in: PubMed
    117. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009; (3):CD004289. PMID: 19588351.
      View in: PubMed
    118. Navaneethan SD, Palmer SC, Schreiber MJ, Strippoli GF. Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder. Nephrology (Carlton). 2009 Jun; 14(4):363-6. PMID: 19563376.
      View in: PubMed
    119. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009; (2):CD004289. PMID: 19370598.
      View in: PubMed
    120. Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2009; (2):CD005019. PMID: 19370615.
      View in: PubMed
    121. Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2009; (2):CD007784. PMID: 19370693.
      View in: PubMed
    122. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Mar; 4(3):542-51. PMID: 19261819.
      View in: PubMed
    123. Navaneethan SD, Yehnert H. Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009 Nov-Dec; 5(6):662-5. PMID: 19359221.
      View in: PubMed
    124. Navaneethan SD, Taylor J, Goldman B, Bose A. Anti-neutrophil cytoplasmic antibody associated crescentic IgA nephropathy in hematopoietic stem cell transplantation. Clin Nephrol. 2009 Jan; 71(1):59-62. PMID: 19203551.
      View in: PubMed
    125. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Feb; 4(2):261-72. PMID: 19073785.
      View in: PubMed
    126. Navaneethan SD, Lohmeier TE, Bisognano JD. Baroreflex stimulation: A novel treatment option for resistant hypertension. J Am Soc Hypertens. 2009 Jan-Feb; 3(1):69-74. PMID: 20409946.
      View in: PubMed
    127. Navaneethan SD, Beddhu S. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant. 2009 Apr; 24(4):1260-6. PMID: 19033255.
      View in: PubMed
    128. Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2009 Apr; 53(4):617-27. PMID: 19027212.
      View in: PubMed
    129. Collins M, Navaneethan SD, Chung M, Sloand J, Goldman B, Appel G, Rovin BH. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis. 2008 Dec; 52(6):1158-62. PMID: 18823685.
      View in: PubMed
    130. Ferrantino M, Navaneethan SD, Sloand JA. Pantoea agglomerans: an unusual inciting agent in peritonitis. Perit Dial Int. 2008 Jul-Aug; 28(4):428-30. PMID: 18556394.
      View in: PubMed
    131. Navaneethan SD, Nigwekar SU. Lack of permanent access in late referrals and its implications: not to be forgotten. Am J Med. 2008 Jun; 121(6):e17; author reply e19. PMID: 18501211.
      View in: PubMed
    132. Nigwekar SU, Rajda J, Navaneethan SD. Hospitalist care and length of stay in patients with hip fracture: a systematic review. Arch Intern Med. 2008 May 12; 168(9):1010-1. PMID: 18474766.
      View in: PubMed
    133. Navaneethan SD, Aloudat S, Singh S. A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol. 2008; 9:3. PMID: 18298850.
      View in: PubMed
    134. Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ. 2008 Mar 22; 336(7645):645-51. PMID: 18299289.
      View in: PubMed
    135. Navaneethan SD, Viswanathan G, Strippoli GF. Meta-analysis of mycophenolate mofetil in IgA nephropathy. Nephrology (Carlton). 2008 Feb; 13(1):90. PMID: 18199113.
      View in: PubMed
    136. Navaneethan SD, Mooney R, Sloand J. Pseudo-anion gap acidosis. NDT Plus. 2008 Apr; 1(2):94-96. PMID: 28657030.
      View in: PubMed
    137. Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis. Thromb Haemost. 2008 Jan; 99(1):38-43. PMID: 18217132.
      View in: PubMed
    138. Jeevanantham V, Zareba W, Navaneethan S, Fitzgerald D, Yu CM, Achilli A, Bax J, Daubert J. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J. 2008; 15(3):230-6. PMID: 18651415.
      View in: PubMed
    139. Navaneethan SD, Viswanathan G, Strippoli GF. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs. 2008; 68(15):2095-104. PMID: 18840001.
      View in: PubMed
    140. Navaneethan SD, Jeevanantham V, Nigwekar SU. Prevalence and predictors of lack of permanent vascular access in early referrals. Am J Kidney Dis. 2007 Oct; 50(4):687. PMID: 17900473.
      View in: PubMed
    141. Navaneethan SD, Viswanathan G, Strippoli GF. Choice of extracorporeal dialysis modality: can it be evidence based? Minerva Urol Nefrol. 2007 Sep; 59(3):261-7. PMID: 17912223.
      View in: PubMed
    142. Viswanathan G, Navaneethan SD. An overlooked differential diagnosis of acute chest pain. South Med J. 2007 Aug; 100(8):850. PMID: 17713317.
      View in: PubMed
    143. Navaneethan SD, Nigwekar S, Sengodan M, Anand E, Kadam S, Jeevanantham V, Grieff M, Choudhry W. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored? Nephron Clin Pract. 2007; 106(3):c113-8. PMID: 17522473.
      View in: PubMed
    144. Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC. Haemoglobin targets: we were wrong, time to move on. Lancet. 2007 Feb 3; 369(9559):346-50. PMID: 17276756.
      View in: PubMed
    145. Nigwekar SU, Navaneethan SD. Timely referral alone may not be enough for patients with chronic kidney disease. Mayo Clin Proc. 2007 Feb; 82(2):252-3. PMID: 17290737.
      View in: PubMed
    146. Bakare M, Shrivastava R, Jeevanantham V, Navaneethan SD. Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients. South Med J. 2007 Feb; 100(2):140-4. PMID: 17330682.
      View in: PubMed
    147. Jeevanantham V, Shrivastava R, Nannapaneni S, Khan A, Sengodan M, Nautiyal A, Navaneethan S, Hsi D. Elevated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea. Indian Heart J. 2007 Jan-Feb; 59(1):64-8. PMID: 19098338.
      View in: PubMed
    148. Navaneethan SD, Singh S. A systematic review of barriers in access to renal transplantation among African Americans in the United States. Clin Transplant. 2006 Nov-Dec; 20(6):769-75. PMID: 17100728.
      View in: PubMed
    149. Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006; (4):CD006257. PMID: 17054288.
      View in: PubMed
    150. Strippoli GF, Navaneethan SD, Craig JC. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2006; (4):CD003967. PMID: 17054191.
      View in: PubMed
    151. Navaneethan SD, Bonifati C, Schena FP, Strippoli GF. Evidence for optimal hemoglobin targets in chronic kidney disease. J Nephrol. 2006 Sep-Oct; 19(5):640-7. PMID: 17136694.
      View in: PubMed
    152. Navaneethan SD, Kannan VS, Osowo A, Shrivastava R, Singh S. Concomitant intracranial aneurysm and carotid artery stenosis: A therapeutic dilemma. South Med J. 2006 Jul; 99(7):757-8. PMID: 16866060.
      View in: PubMed
    153. Navaneethan SD, Querques M, Bonifati C, Strippoli GF. Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection. Diabetes Educ. 2006 Jul-Aug; 32(4):596-602. PMID: 16873597.
      View in: PubMed
    154. Navaneethan SD, Sankarasubbaiyan S, Gross MD, Jeevanantham V, Monk RD. Tacrolimus-associated hypomagnesemia in renal transplant recipients. Transplant Proc. 2006 Jun; 38(5):1320-2. PMID: 16797291.
      View in: PubMed
    155. Navaneethan SD, Pansini F, Strippoli GF. Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials. PLoS Med. 2006 May; 3(5):e123. PMID: 16719546.
      View in: PubMed
    156. Navaneethan SD, Nautiyal A, Abdel-Gadir K, Shrivastava R, Parameswaran G, DiSalle MR, Haley J. Hospitalist physicians as educators in a community hospital: the trainee's view. South Med J. 2006 May; 99(5):550-1. PMID: 16711328.
      View in: PubMed
    157. Osowo A, Fetten J, Navaneethan S. Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms. South Med J. 2006 Feb; 99(2):188-9. PMID: 16509562.
      View in: PubMed
    158. Rivero M, Karlic A, Navaneethan SD, Singh S. Possible cocaine-induced acute renal failure without rhabdomyolysis. J Nephrol. 2006 Jan-Feb; 19(1):108-10. PMID: 16523435.
      View in: PubMed
    159. Bonifati C, Pansini F, Torres DD, Navaneethan SD, Craig JC, Strippoli GF. Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice. Int J Artif Organs. 2006 Jan; 29(1):41-9. PMID: 16485238.
      View in: PubMed
    160. Navaneethan SD, Singh S, Choudhry W. Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature. J Nephrol. 2005 Sep-Oct; 18(5):613-5. PMID: 16299690.
      View in: PubMed
    161. Navaneethan SD, Venkatesh S, Shrivastava R, Mehta J, Israel R. Recurrent pleural and pericardial effusions due to sarcoidosis. PLoS Med. 2005 Mar; 2(3):e63. PMID: 15783254.
      View in: PubMed
    162. Navaneethan S, Venkatesh S, Nannapaneni S, Shrivastava R. Educational intervention: a tool for decreasing medication errors. Int J Qual Health Care. 2005 Feb; 17(1):83. PMID: 15668315.
      View in: PubMed
    163. Navaneethan SD, Shrivastava R. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2004; (4):CD004289. PMID: 15495097.
      View in: PubMed
    NAVANEETHAN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description